Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
10/2007
10/25/2007WO2007119103A1 Labeled macrophages and methods of use thereof
10/25/2007WO2007118658A1 Method of isolating postnatal and/or adult epithelial stem and precursor cells of the intestine with the aid of a monoclonal antibody
10/25/2007WO2007118423A1 Human recombinant erytheropoietin fusion proteins, preparing methods and uses thereof
10/25/2007WO2007103379A9 Method for endothelial cell extraction from adipose tissues
10/25/2007WO2007061750A3 Adipose tissue derived stromal cells for the treatment of neurological disorders
10/25/2007WO2007047509A3 Differentiation of non-embryonic stem cells to cells having a pancreatic phenotype
10/25/2007WO2007046962A3 Cell lines harboring hepatitis virus and methods for using thereof
10/25/2007WO2007033330A3 Stem cells
10/25/2007WO2007024589A3 Phagocyte enhancement therapy for atherosclerosis
10/25/2007WO2007020611B1 Adult human neural stem/progenitor cells from the olfactory epithelium and olfactory lamina propria, isolation method, proliferation and differentiation in serum free culture medium and utilization for transplantation
10/25/2007WO2007016291A3 Transition state structure of 5'-methylthioadenosine/s-adenosylhomocysteine nucleosidases
10/25/2007WO2007002641A3 Method for identifying cart receptor and uses thereof
10/25/2007WO2007002365A3 Modulation of amino acid metabolism in the hypothalamus
10/25/2007WO2006033999A3 Modified adenovirus containing a fiber replacement protein
10/25/2007WO2005034877A3 G-csf transferrin fusion proteins
10/25/2007WO2002099074A3 Slc7s as modifiers of the p53 pathway and methods of use
10/25/2007US20070250964 Ice Recrystallisation Inhibition Protein or Antifreeze Proteins from Deschampsia, Lolium and Festuca Species of Grass
10/25/2007US20070250963 Multiple Stress-Inducible Peroxidase Promoter Derived From Ipomoea Batatas
10/25/2007US20070250959 Maize promoter active in silks, stalk nodes, roots and leaf sheaths
10/25/2007US20070250958 Cotton Cultivar PM 3535 BG/RR
10/25/2007US20070250957 Group III nitride semiconductor light emitting device having a light emitting layer (6) bonded to a crystal layer composed of an n-type or p-type Group III nitride semiconductor, the Group III nitride semiconductor light emitting device being characterized by comprising an n-type Group III nitride
10/25/2007US20070250956 modulating expression of a GATA transcription factor gene in the plant cell; modulates agronomic traits such as improved fertilizer untilization (nitrogen utilization), crop yield, lipid biosynthesis
10/25/2007US20070250955 Plants and seeds of corn variety i796483
10/25/2007US20070250954 Plants and seeds of corn variety i285290
10/25/2007US20070250953 Plants and seeds of corn variety i877879
10/25/2007US20070250952 Plants and seeds of corn variety i112311
10/25/2007US20070250951 Plants and seeds of corn variety i226276
10/25/2007US20070250950 Plants and seeds of corn variety i291273
10/25/2007US20070250949 Plants and seeds of corn variety i286346
10/25/2007US20070250948 Vectors useful in plant transformations; useful for transferring and integrating one polynucleotide into another via bacterial-mediated transformation
10/25/2007US20070250947 Identification and use of target genes for control of plant parasitic nematodes
10/25/2007US20070250946 Monocot Ahass Sequences and Methods of Use
10/25/2007US20070250945 Usage of Mad-Box Genes in Fruit & Seed Development by Regulating Active Gibberellin Synthesis
10/25/2007US20070250941 VEGF Receptor Conditional Knockout Animals and Methods of Use
10/25/2007US20070250165 Muscle-Polymer Constructs for Bone Tissue Engineering
10/25/2007US20070249813 recombinant human antibodies containing CDR3 domain having an amino acid sequence with alanine substitutions that specifically bind to human tumor necrosis factor alpha (hTNF alpha ) to treat autoimmune disorders ( rheumatic arthritis, allergy, multiple sclerosis, autoimmune diabetes)
10/25/2007US20070249565 Class of Gamma Delta T Cells Activators and Use Thereof
10/25/2007US20070249549 Compounds and Methods for Rna Interference of the P65 Subunit of Nf-Kappa-B
10/25/2007US20070249538 tumor necrosis factor (TNF) antagonists and corresponding nucleic acids; inflammatory diseases; the proteins lack exon 7 and which can bind TNF and can act as a TNF antagonist
10/25/2007US20070249533 Il-17a and il-17f antagonists and methods of using the same
10/25/2007US20070249531 Method for the Detection of Autoantibodies Against Specific Peptides and Its Use in Diagnosis and Treatment of Pregnancy-Loss or Infertility
10/25/2007US20070249530 Bcma Polypeptides and Uses Thereof
10/25/2007US20070249521 polypeptide having antimicrobial activity, having an amino acid sequence selected from e.g. Arg Arg Arg Pro Pro Arg Leu Pro Arg Pro Phe Pro; Phe Arg Pro Pro Pro Arg Pro Arg Pro Leu Pro Val; detergents, animal feed
10/25/2007US20070249052 Cartilage Regeneration By Generation Of Chondrons Under High Concentrations Of Magnesium
10/25/2007US20070249051 Vinyl-phenyl derivatives for inflammation and immune-related uses
10/25/2007US20070249050 Substituted aromatic compounds for inflammation and immune-related uses
10/25/2007US20070249049 For modulating gene expression pathways, including those relying on mechanisms of action such as RNaseH, RNAi and dsRNA enzymes, as well as other antisense mechanisms based on target degradation or target occupancy; of therapeutic, diagnostics, and research applications; nuclease resistance
10/25/2007US20070249048 useful as immunosuppressive, anti-inflammatory and anticancer agents; prepared by reaction of a starting triptolide compound with selenium dioxide.
10/25/2007US20070249047 Using human fetal blood multi-lineage pluripotent cells to generate type II alveolar cells; treating leukemias and genetic blood disorders
10/25/2007US20070249046 Apparatus and method for the static application of therapeutic ultrasound and stem cell therapy of living tissues
10/25/2007US20070249045 Adipose derived adult stem cells in hepatic regeneration
10/25/2007US20070249044 Microstructures in three dimensional gel suspensions for growth of cells
10/25/2007US20070249020 Cytokine zcytor17 ligand polypeptides and polynucleotides
10/25/2007US20070249016 Method for Gene Amplification
10/25/2007US20070249015 Method of isolation and purification of trypsin from pronase protease and use thereof
10/25/2007US20070249009 Compositions and methods for altering RNAi
10/25/2007US20070248998 new bone marrow stromal stem cell (BMSSC) marker; for use in selecting a population of cells enriched in BMSSCs, from bone marrow cells, adipose cells, or peripheral blood
10/25/2007US20070248972 Page-4, an X-linked gage-like gene expressed in normal and neoplastic prostate, testis and uterus, and uses therefor
10/25/2007US20070248963 method for identifying pre-neoplastic and/or neoplastic states in mammals
10/25/2007US20070248956 Methods and Compositions for Autism Risk Assessment
10/25/2007US20070248945 Stem cells derived from uniparental embryos and methods of use thereof
10/25/2007US20070248942 bringing virus-containing blood into contact with a material for selectively removing viruses and leukocytes which comprises a water-insoluble carrier having a surface for adsorbing or removing viruses and leukocytes; useful when the blood contains hepatitis C virus
10/25/2007US20070248941 improves/extends period of viability of packed red blood cells and platelet concentrations; improves circulation half life upon transfusion
10/25/2007US20070248716 Method For the Production of a Biological Material Composition Having an Animal Origin
10/25/2007US20070248706 Compositions and Methods for Activating Toll-like Receptor 4
10/25/2007US20070248659 Individualized cancer therapy
10/25/2007US20070248644 Muller Stem Cells
10/25/2007US20070248627 Gene Therapy for Tumors Using Minus-Strand Rna Viral Vectors Encoding Immunostimulatory Cytokines
10/25/2007US20070248626 Recombinant toxin fragments
10/25/2007US20070248616 Canine Respiratory Coronavirus (Crcv) Spike Protein, Polymerase and Hemagglutinin/Esterase
10/25/2007US20070248612 Isolated Plasma And Method For Hyperimmunisation And Plasma Collection
10/25/2007US20070248607 Negative immunomodulation of immune responses by nkg2d-positive cd4+ cells
10/25/2007US20070248606 Treatment of Alzheimer's disease
10/25/2007US20070248604 Inhibits fibroblast growth factor (FGF); used to treat a tumor, a cancer, and/or a cell proliferative disorder
10/25/2007US20070248601 Non-Human Transgenic Mammal for the Constant Region of the Class a Human Immunoglobulin Heavy Chain and Applications Thereof
10/25/2007US20070248600 selection of a CHO (chinese hamster ovary) cell that recombinantly produces an Fc region expressed and glycosylated monoclonal antibody comprising human IgG1 or IgG3 heavy chain constant domains; for manufacture of a medicament
10/25/2007US20070248598 Recombinant anti-VLA4 antibody molecules
10/25/2007US20070248593 Identifying and characterizing novel human secreted proteins and their genes ; promotes vascularization; screening methods
10/25/2007US20070248592 Agent for inhibiting proliferation of neural stem cells
10/25/2007US20070248590 Modulators of CDC2-like kinases (CLKS) and methods of use thereof
10/25/2007US20070248589 Spatial for Altering Cell Proliferation
10/25/2007US20070248588 Novel Compositions and Methods for the Treatment of Immune-Related Diseases
10/25/2007US20070248584 Immunomodulating Compositions, Uses Therefore and Processes for Their Production
10/25/2007US20070248580 Identification and Isolation of Multipotent Cells From Non-Osteochondral Mesenchymal Tissue
10/25/2007US20070248579 Use of Secreted Protein Products for Preventing and Treating Pancreatic Diseases and/or Obesity and/or Metabolic Syndrome
10/25/2007US20070248576 Regulation of the serotonin reuptake transporter and disease
10/25/2007US20070248574 Methods of Making and Using Skin-Derived Stem Cells
10/25/2007US20070248545 Use of the receptor GPR86
10/25/2007US20070248543 Chicken Deoxycytidine and Deoxyadenosine Kinase Enzymes and Their Use
10/25/2007US20070248535 Methods to treat or prevent hormone-resistant prostate cancer using siRNA specific for protocadherin-PC, or other inhibitors of protocadherin-PC expression or activity
10/25/2007DE102006018392A1 Therapeutische Zielmoleküle zur Entwicklung neuartiger Medikamente für degenerative Erkrankungen Therapeutic targets for developing novel drugs for degenerative diseases
10/25/2007CA2649706A1 Cell therapy: a method and a composition for treating diabetes
10/25/2007CA2649333A1 Cellular labeling and quantification for nuclear magnetic resonance techniques
10/25/2007CA2649325A1 Kits and methods for generating 5' capped rna
10/25/2007CA2649250A1 Dopaminergic neuron progenitor cell marker 187a5
10/25/2007CA2649148A1 Taurine transporter gene
10/25/2007CA2648548A1 Survival and development of neural cells
10/25/2007CA2648263A1 Permuted and nonpermuted luciferase biosensors
10/25/2007CA2646491A1 Differentiation of multi-lineage progenitor cells to respiratory epithelial cells
10/25/2007CA2646253A1 Method for cloning and expression of nrui restriction endonuclease
1 ... 759 760 761 762 763 764 765 766 767 768 769 770 771 772 773 774 775 776 777 778 779 ... 1827